FDA Chief Defends Hydrocodone Painkiller Approval
By Sindhu Sundar ( March 13, 2014, 5:42 PM EDT) -- The U.S. Food and Drug Administration adequately determined that the controversial new painkiller Zohydro ER offered benefits that outweigh its risks of abuse — a rampant problem with such prescription hydrocodone drugs — particularly for patients who cannot tolerate existing hydrocodone medications, FDA Commissioner Margaret Hamburg said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.